NCT01888198 2025-07-25
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
Memorial Sloan Kettering Cancer Center
Active not recruiting
Clinical Trials
6 trialsNCT06955910 2025-07-10
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Recruiting
NCT00505310 2022-08-30
Biobehavioral Effects of Emotional Expression in Cancer
M.D. Anderson Cancer Center
Phase NA Completed
NCT01392183 2021-09-20
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02060370 2020-02-27
Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01447199 2020-01-07
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
M.D. Anderson Cancer Center
Unknown